Accelerate Diagnostics, Inc. provided earnings guidance for the year 2022. For the quarter, the company expected to come in just below the low end of revenue guidance of $13 million to $14 million for the year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 USD | -1.71% |
|
-1.71% | -70.66% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-70.66% | 27.63M | |
+0.20% | 205B | |
+3.65% | 178B | |
+31.11% | 158B | |
+32.35% | 112B | |
+1.79% | 64.58B | |
+22.60% | 55.34B | |
-3.27% | 46.64B | |
-9.79% | 36.78B | |
-0.58% | 34.85B |
- Stock Market
- Equities
- AXDX Stock
- News Accelerate Diagnostics, Inc.
- Accelerate Diagnostics, Inc. Provides Earnings Guidance for the Year 2022